These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28259649)

  • 21. Ligands of Therapeutic Utility for the Liver X Receptors.
    Komati R; Spadoni D; Zheng S; Sridhar J; Riley KE; Wang G
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28067791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural modulators of liver X receptors.
    Huang C
    J Integr Med; 2014 Mar; 12(2):76-85. PubMed ID: 24666673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis.
    Xu P; Zhai Y; Wang J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress of the relationship between liver X receptor and inflammatory-related diseases].
    Gao BC; Chen Q; Sun T; Wang DM; Xiao J
    Sheng Li Xue Bao; 2018 Jun; 70(3):335-341. PubMed ID: 29926076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advances on liver X receptors].
    Wang Q; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver x receptors: a potential therapeutic target for modulating the atherosclerotic process.
    Parikh N; Frishman WH
    Cardiol Rev; 2010; 18(6):269-74. PubMed ID: 20926935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting liver X receptors in cancer therapeutics.
    Lin CY; Gustafsson JÅ
    Nat Rev Cancer; 2015 Apr; 15(4):216-24. PubMed ID: 25786697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver X receptors link lipid metabolism and inflammation.
    Schulman IG
    FEBS Lett; 2017 Oct; 591(19):2978-2991. PubMed ID: 28555747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanism of liver X receptors in cancer therapeutics.
    Wang Q; Wang J; Wang J; Zhang H
    Life Sci; 2021 May; 273():119287. PubMed ID: 33667512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging roles for LXRs and LRH-1 in female reproduction.
    Mouzat K; Baron S; Marceau G; Caira F; Sapin V; Volle DH; Lumbroso S; Lobaccaro JM
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):47-58. PubMed ID: 22750099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological roles of liver X receptors in immune cells.
    Pascual-García M; Valledor AF
    Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):235-49. PubMed ID: 22696047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
    Bovenga F; Sabbà C; Moschetta A
    Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging roles of liver X receptors and their ligands in cancer.
    Lin CY; Vedin LL; Steffensen KR
    Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LXR Regulation of Brain Cholesterol: From Development to Disease.
    Courtney R; Landreth GE
    Trends Endocrinol Metab; 2016 Jun; 27(6):404-414. PubMed ID: 27113081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X Receptors and Their Implications in the Physiology and Pathology of the Peripheral Nervous System.
    Sundaram VK; Massaad C; Grenier J
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.